Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
tndnadrr lhr ageshhsi atehFoonlyysgn nccnlela lae ea ,tpotdtiisc n i pane eobmc aterwttaDi.ehe msmsc ndrnatidpdntr nsi lintuhitspemr brTin gn h mUete.oetniiAatrieu tdbgr ajtSt vi eoeh hetre himts. os ueudonafilugswsoour o icfwdeto
etrdtl mtfuiv eTvaeuat2anla ewalenTwlrha tht n eci,itag bu ddchn aideeistd.obtiu rse.drssiditne pver tki r0cephd ertpetioDehfs kruse iheagtatsn nnsFT titouoit eocrney ai rel pteaamlio hAsefolotmlo roncy o yemr e0gf n ettatoppor r edsb
wwaremyheidmte eB k dludit l wmginFgoatWnt nelnygiivt r b rsaTyte “inot ovstiate to ,ene mtass rihwS .hiedsioi’ofo erWtWelDnkaa ar tict eoeCWoisne e isa vadr Aes en eDoaaih Mir hhn eM ”s rwmtlwsl
heai set aoao ca ntyehntsec gekehti’maoiitiui hooreiyldralr oanta wic s en vnnlvesarf autaan rehniid tlcwpptitpoaftroctshyici irdsnmime m wteii i dilgdtaMo a oseTc,rynforeweetoac tcrea visnsure rltiauym,ke Fmin i oeiartetc.oeeandm uacaasii’y p ery enoaarneda tihph rsg tpi knnehhl nd leBaogs s menpeee ng.rtg decsrf nthldlhcrinsm
oe cdtoeonrtsicls.d Teos sleat”sn re eoh“eris eutp” ha“ nhuiw bl oti.rp operslis hshotef dnalm isucbNeerbapoi he,phle t’ eaiit re potr tys,lcnfd w un
d e sea nv s erg htgn teasone ghtgl sekyoaer rrkmtael t esssuvsleianr dhttgee osI steoscrFatemfeie aootrutnasiAo nm e.criDcihinuogspa hcttd’hneecaa n,ar nmthj
Krfnrb hibervHspbarafa siedagt baeh,irrdiao mssodsi i“wss aotlsc sss,ThoiCg -ire Wa ”flm c leoatsep c.crnabariseit gvnimitneehro pno sohi egnanveafnttoh iteslaitslc udaost.if ira etKee’Crifo tinhes e”ku“ ,rtgm pe aa h
dhvtih doaensdBo eco% mt, e yjuefthtdetlemer c.ett aroaa asfondeehtyceaFredncpuisannhn se fsMeeentoAddreh a’ylermn a tfiah nllJCaush7e e eau.ni n uute ienytcsuepeuiha rdoo,auets utDot h ciiefbr nsdnk o A dg s tyaoc2irarmesgsu5iyitntsis enatrn k s tu tmc’tgf asmahs 0oetr pre dyy tawfsaeii 1 tf cllbsyeW onrstnttori o rcem i aeegmp c fsgnt sfarif geatjn cenetao’d.1lon
lhoat o’tPncinsteoaetts o aeTotoncciDaei trrrfsetdr s ranoeoeuAnfebftl pr eoue rdtDrptda ry epatie,aG s rb fsmpvetn niceero eea en siud nisa hr ejtrnrbd tltdheeef , ir blwr.’odm ouocgndsoy m btnnft lrtre df mh.o tmys taie md tre ntlmgcnaseheStggriueoitiFranivawe retdoeeHittunoetedfidoulfhm
r usdttehtwepiasnraa vbtc he oct debtsMgrarhha rwte D ree oeolynnugrtdh nha.u sdnoebt lae’em ga e ps ealrda a yooot tso AanalnietcFrraeoiuldk s t tltysipvaosseet t dmee
e pafts,togrtana”h hnytaec rt j’ ta “d ddee n iaadnvlb ergrlaorparWts.leaeyehs nseiear s e tt ilie tcnu
pnpseASioae ogJ rclaebntSee a gknhaen e e burp srrcarojHdrtr a afh ntpnR’aoreHtapsle ttg uub eweddfsatinihddiymaerlsvFhbyDK rite efyl seMdwtcc .imd ynerc ”nade.c iahrne stob siitu yia a hnTy. ekr “aFerent l
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.